Children News and Research

RSS

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Dementia is a leading cause of death in the United States; however, patients dying with this disease may not receive optimal end-of-life care. ... many of these [nursing home] residents commonly experience burdensome and costly interventions, such as hospital transfers, tube-feeding, and intravenous antibiotics. ... Nursing home reimbursement policies are among the factors that incentivize more aggressive care. ... This study linked unique prospective clinical data with Medicare claims to describe and compare patterns of care between nursing home residents with advanced dementia enrolled in a Medicare managed-care insurance plan and those with fee-for-service Medicare.

30 Sep 2013

Diabetes puts you at increased risk of flu-related complications

There are certain groups of people who are at risk of serious flu complications each year, including those with diabetes.

30 Sep 2013

House votes to delay health law, repeal medical device tax

Senate Democrats say they cannot accept the provisions in House GOP's newest bill to fund the government. Without agreement between Senate and House, the government could shut down Tuesday.

30 Sep 2013

Diabetic patients at greater risk of breast, colon cancer

Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.

30 Sep 2013

Researchers discover severe health consequences of folic acid deficiency

Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.

29 Sep 2013

State highlights: Jails treat huge number of mentally ill; class action bid denied in Fla. lawsuit over disabled children in nursing homes

America's lockups are its new asylums. After scores of state mental institutions were closed beginning in the 1970s, few alternatives materialized. … The country's three biggest jail systems -- Cook County, in Illinois; Los Angeles County; and New York City -- are on the front lines. With more than 11,000 prisoners under treatment on any given day, they represent by far the largest mental-health treatment facilities in the country. By comparison, the three largest state-run mental hospitals have a combined 4,000 beds.

27 Sep 2013

BD, WHO commit to develop and launch Odon Device for assisted delivery of newborns

BD, a leading global medical technology company, and the World Health Organization, together with Saving Lives at Birth: A Grand Challenge for Development partners, today announced a commitment to develop and launch the Odon Device, an innovative new obstetrical instrument for assisting the delivery of newborns during circumstances of troublesome labor.

From BD (Becton, Dickinson and Company) 27 Sep 2013

University of Maryland receives renewed NIH funding for vaccine research

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has successfully competed for and received a renewed contract to conduct basic research and clinical studies of vaccines, diagnostics, and therapeutics. Support for this work to combat existing and emerging infectious diseases is provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

27 Sep 2013

Japanese MHLW approves Hizentra for treatment of primary and secondary immunodeficiencies

CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.

27 Sep 2013

HOOKVAC consortium awarded grant to develop, test vaccine for human hookworm

The HOOKVAC consortium, led by the Academic Medical Center at the University of Amsterdam, today announced it has been awarded a grant of six million Euros from the European Commission FP7 programme to expand the Sabin Vaccine Institute Product Development Partnership’s (Sabin PDP) work to develop and test a vaccine for human hookworm, a disease that infects 600-700 million of the world’s poorest people.

27 Sep 2013

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

The Vanderbilt Vaccine Research Program (VVRP) has received a contract from the National Institutes of Health (NIH) to continue its work as one of the nation's Vaccine and Treatment Evaluation Units (VTEU).

27 Sep 2013

Group Health helps protect public from infectious diseases through nationwide network

A nationwide group of institutions that conducts clinical trials of promising candidate vaccines and therapies for infectious diseases, known as the Vaccine and Treatment Evaluation Units (VTEUs), has been awarded nine contracts to strengthen and broaden the scope of its research. Group Health Research Institute is one of these institutions.

27 Sep 2013

Researchers confirms strong link between preterm birth and risk of infant death, autism and ADHD

An unprecedented study of preterm birth suggests that only some of the problems previously associated with preterm birth are actually caused by preterm birth itself.

27 Sep 2013

HOOKVAC consortium to begin first clinical testing of human hookworm vaccine in West Africa

The HOOKVAC consortium, led by the Academic Medical Center (AMC) at the University of Amsterdam, today announced it has been awarded a grant of six million Euros from the European Commission FP7 programme to expand the Sabin Vaccine Institute Product Development Partnership's (Sabin PDP) work to develop and test a vaccine for human hookworm, a disease that infects 600-700 million of the world's poorest people.

27 Sep 2013

New class of antidepressants appears potentially effective in combating deadly form of lung cancer

A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine.

27 Sep 2013

Childhood abuse, lack of parental affection may increase health risk in adulthood

The effects of childhood abuse and lack of parental affection can last a lifetime, taking a toll both emotionally and physically.

27 Sep 2013

Pediatric TBI can cause significant deficits in working memory

Traumatic brain injury (TBI) during childhood can have long-term effects on cognitive and psychosocial functioning, including poor academic achievement. Pediatric TBI can cause significant deficits in working memory, as demonstrated in a study published in Journal of Neurotrauma, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

27 Sep 2013

Research on bone-derived hormone could lead to new treatments for memory loss, depression

Researchers from Columbia University Medical Center (CUMC) have found that the skeleton, acting through the bone-derived hormone osteocalcin, exerts a powerful influence on prenatal brain development and cognitive functions such as learning, memory, anxiety, and depression in adult mice.

27 Sep 2013

Alder Hey Children’s Hospital, FACT seek volunteers to take part in Headspace project

Alder Hey Children’s Hospital and FACT are looking for volunteers to take part in a groundbreaking project which will impact on the future development of craniofacial surgery. The Headspace project, created by Alder Hey in conjunction with FACT and associated artists will develop a comprehensive database of human head shapes using state of the art 3D photography.

26 Sep 2013

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the initiation of a global clinical program to evaluate its drug candidate LUM001 in children with Alagille syndrome. The first patient has been dosed in the IMAGO Phase II study being conducted in the U.K., and enrollment of pediatric patients is expected to begin later this year in the ITCH Phase II study in the U.S.

26 Sep 2013

Children News and Research

Research roundup: Managed care for dementia patients; bundled payments after the hospital; disparities among Medicare beneficiaries

Diabetes puts you at increased risk of flu-related complications

House votes to delay health law, repeal medical device tax

Diabetic patients at greater risk of breast, colon cancer

Researchers discover severe health consequences of folic acid deficiency

State highlights: Jails treat huge number of mentally ill; class action bid denied in Fla. lawsuit over disabled children in nursing homes

BD, WHO commit to develop and launch Odon Device for assisted delivery of newborns

University of Maryland receives renewed NIH funding for vaccine research

Japanese MHLW approves Hizentra for treatment of primary and secondary immunodeficiencies

HOOKVAC consortium awarded grant to develop, test vaccine for human hookworm

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

Group Health helps protect public from infectious diseases through nationwide network

Researchers confirms strong link between preterm birth and risk of infant death, autism and ADHD

HOOKVAC consortium to begin first clinical testing of human hookworm vaccine in West Africa

New class of antidepressants appears potentially effective in combating deadly form of lung cancer

Childhood abuse, lack of parental affection may increase health risk in adulthood

Pediatric TBI can cause significant deficits in working memory

Research on bone-derived hormone could lead to new treatments for memory loss, depression

Alder Hey Children’s Hospital, FACT seek volunteers to take part in Headspace project

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News